# Irreversible left-ventricular lead electrical failure from conductor externalization managed with left bundle branch area pacing: a case report

**Authors:** Jaber Almohammad, Ahmed Almarzuqi, Habib Rehman Khan

PMC · DOI: 10.1093/ehjcr/ytag047 · 2026-01-25

## TL;DR

A patient with a failed heart implant was successfully treated with a new pacing method after the original lead failed due to conductor externalization.

## Contribution

Demonstrates the use of left bundle branch area pacing as a solution for irreversible LV lead failure due to conductor externalization.

## Key findings

- The patient's LV lead failed due to conductor externalization confirmed during extraction.
- LBBAP was successfully implanted with low capture threshold and stable sensing.
- The patient's heart function improved significantly after LBBAP implantation.

## Abstract

Conductor externalization is a recognized mechanism of transvenous lead failure. In left-ventricular (LV) coronary-sinus (CS) leads, irreversible electrical failure requiring extraction is uncommon. Conduction system pacing with left bundle branch area pacing (LBBAP) can provide a physiological alternative when CS re-implantation is not feasible.

A 67-year-old man with non-ischaemic cardiomyopathy and reduced LV ejection fraction (EF) secondary to infective endocarditis with severe aortic/mitral regurgitation underwent bioprosthetic aortic valve replacement with mitral repair and cardiac resynchronization therapy-defibrillator implantation in 2021 after drug-associated torsade de pointes and ventricular fibrillation arrest. He underwent transcatheter edge-to-edge mitral repair in June 2024. At routine review in October 2024, he was clinically well and asymptomatic; LV lead testing showed very high impedance (>3000 Ω), threshold 5.75 V at 1.0 ms, and intermittent loss of capture. Chest radiography showed stable lead position. At revision in March 2025, the extracted LV lead displayed conductor externalization, and CS re-implantation was precluded by a small, unwireable anterolateral branch. LBBAP was implanted with low capture threshold and stable sensing; the generator was replaced without complications. At 1-month follow-up, the LV EF was 20–25% (previously 10–15% in 2024); by August 2025 he was New York Heart Association (NYHA) class I and euvolaemic with stable weight.

This case demonstrates persistent electrical failure in LV CS lead with extraction-confirmed conductor externalization, contrasts with prior reports of electrically silent or transient disturbance, and supports LBBAP as a practical physiological option when CS re-implantation is not feasible.

## Linked entities

- **Diseases:** infective endocarditis (MONDO:0000565), ventricular fibrillation (MONDO:0000190)

## Full-text entities

- **Diseases:** MR (MESH:D008944), non (MESH:C580335), VF (MESH:D014693), QT prolongation (MESH:D008133), electrical (MESH:D004556), CS (MESH:D003323), thromboembolism (MESH:D013923), ischaemic cardiomyopathy (MESH:D009202), chest pain (MESH:D002637), peripheral oedema (MESH:D010523), palpitations (MESH:D006331), LV abnormalities (MESH:D018487), torsade de pointes (MESH:D016171), Heart-Failure (MESH:D006333), arrhythmia (MESH:D001145), aortic valve replacement (MESH:D001024), IE (MESH:D004696), cardiac arrest (MESH:D006323), infection (MESH:D007239), fracture (MESH:D050723), aortic (MESH:D001018)
- **Chemicals:** silicone (MESH:D012828), amiodarone (MESH:D000638), DDD (MESH:D003632), CSP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924164/full.md

---
Source: https://tomesphere.com/paper/PMC12924164